Sep 11, 2025 9:54 pm EDT Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program
Aug 25, 2025 2:11 pm EDT Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs
Jul 15, 2025 5:34 pm EDT Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division
May 12, 2025 5:14 pm EDT Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering
May 8, 2025 5:00 pm EDT Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering
